Real-time enrollment status for this heart disease clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 5:03 AM UTC
| NCT Number | NCT07037433 |
| Recruiting Status | Recruiting |
| Condition | Heart Disease |
| Phase | PHASE3 |
| Target Enrollment | 12,800 participants |
| Active Locations | 140 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 18, 2026: Clinical trial NCT07037433 is currently recruiting participants. This phase3 study for heart disease is actively seeking new participants at 140 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07037433 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 140 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07037433 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.